Astellas Pharma Operating Income Over Time
| YPH Stock | EUR 13.48 0.20 1.46% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out Astellas Pharma Performance and Astellas Pharma Correlation. Astellas |
Cross Equities Operating Income Analysis
Compare Astellas Pharma and related stocks such as Treasure ASA, PT Bank Maybank, and MOOG INC CL Operating Income Over Time
| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| BOZA | 2 T | 2 T | 2 T | 2 T | 989.5 B | 1.5 T | 2.6 T | 2.8 T | 3 T | 2.6 T | 2.6 T | 2.6 T | 2.6 T | 2.6 T | 2.6 T | 3 T | 2.4 T |
| MO7R | 262.7 M | 262.7 M | 262.7 M | 262.7 M | 262.7 M | 262.7 M | 262.7 M | 262.7 M | 262.7 M | 262.7 M | 262.7 M | 262.7 M | 316.3 M | 398.4 M | 409.7 M | 471.2 M | 381.5 M |
| UN0 | (3.5 B) | (3.5 B) | (3.5 B) | (3.5 B) | (3.5 B) | (3.5 B) | (3.5 B) | 354 M | 535 M | (532 M) | (218 M) | 4 B | (6.4 B) | 257 M | 1.3 B | 1.5 B | 1.6 B |
Astellas Pharma and related stocks such as Treasure ASA, PT Bank Maybank, and MOOG INC CL Operating Income description
Operating Income is the amount of profit realized from Astellas Pharma operations after accounting for operating expenses such as cost of goods sold (COGS), wages and depreciation. Operating income takes the gross income and subtracts other operating expenses and then removes depreciation. Operating Income of Astellas Pharma is typically a synonym for earnings before interest and taxes (EBIT) and is also commonly referred to as operating profit or recurring profit. Earnings before interest and taxes (EBIT), representing the amount of profit a company generates from its operations.My Equities
My Current Equities and Potential Positions
| Astellas Pharma | YPH |
Specialization | Health Care, Pharmaceuticals, Biotechnology & Life Sciences |
| Business Address | 2-5-1, Nihonbashi-Honcho, Chuo, |
| Exchange | Frankfurt Exchange |
EUR 13.48
Other Information on Investing in Astellas Stock
Astellas Pharma financial ratios help investors to determine whether Astellas Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Astellas with respect to the benefits of owning Astellas Pharma security.